← Back to Screener
Stablecoin Development Corporation (SDEV)
Price$1.65
Favorite Metrics
Price vs S&P 500 (26W)-79.80%
Price vs S&P 500 (4W)-8.12%
Market Capitalization$43.40M
Indicated Dividend Yield (Annual)0.00%
All Metrics
P/CF (Annual)16.06x
Revenue Growth (3Y)5.12%
Cash Flow / Share (Quarterly)$0.11
Price vs S&P 500 (YTD)-102.39%
Gross Margin (TTM)54.56%
Net Profit Margin (TTM)-88.52%
EPS (TTM)$-4.09
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$-4.09
Revenue Growth (5Y)8.19%
EPS (Annual)$-2.13
Dividend / Share (Annual)$0.37
ROI (Annual)-216.58%
Gross Margin (Annual)66.26%
Net Profit Margin (5Y Avg)-78.66%
Cash / Share (Quarterly)$0.32
Revenue Growth QoQ (YoY)-78.66%
ROA (Last FY)-211.01%
Revenue Growth TTM (YoY)-74.73%
EBITD / Share (TTM)$-4.01
ROE (5Y Avg)-306.84%
Operating Margin (TTM)-89.93%
Cash Flow / Share (Annual)$0.11
P/B Ratio26.56x
Net Income / Employee (Annual)$-3,611,500
Net Interest Coverage (TTM)-399.56x
ROA (TTM)-460.21%
EPS Incl Extra (Annual)$-2.13
Current Ratio (Annual)7.60x
Quick Ratio (Quarterly)7.33x
3-Month Avg Trading Volume0.42M
52-Week Price Return-42.81%
Revenue / Employee (TTM)$1,415,000
P/S Ratio (Annual)4.44x
Asset Turnover (Annual)2.86x
52-Week High$99.75
Operating Margin (5Y Avg)-76.31%
EPS Excl Extra (Annual)$-2.13
26-Week Price Return-71.65%
Quick Ratio (Annual)7.33x
13-Week Price Return-56.53%
Total Debt / Equity (Annual)0.34x
Current Ratio (Quarterly)7.60x
Revenue / Share Growth (5Y)-23.01%
Asset Turnover (TTM)0.82x
Revenue / Employee (Annual)$4,890,500
Inventory Turnover (Annual)1.81x
Pretax Margin (Annual)-73.71%
Cash / Share (Annual)$0.32
3-Month Return Std Dev154.73%
Gross Margin (5Y Avg)60.92%
Net Income / Employee (TTM)$-14,905,500
ROE (Last FY)-290.89%
Net Interest Coverage (Annual)-152.45x
EPS Basic Excl Extra (Annual)$-2.13
P/FCF (TTM)4.66x
Receivables Turnover (TTM)5.28x
Total Debt / Equity (Quarterly)0.09x
EPS Incl Extra (TTM)$-4.09
Receivables Turnover (Annual)17.04x
ROI (TTM)-104.74%
P/S Ratio (TTM)15.34x
Pretax Margin (5Y Avg)-78.61%
Revenue / Share (Annual)$2.88
Price vs S&P 500 (52W)-73.35%
Year-to-Date Return-94.22%
5-Day Price Return24.43%
EPS Normalized (Annual)$-2.13
ROA (5Y Avg)-95.83%
Net Profit Margin (Annual)-73.85%
Month-to-Date Return31.45%
EBITD / Share (Annual)$-2.11
Operating Margin (Annual)-59.83%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)16.06x
ROI (5Y Avg)-146.64%
LT Debt / Equity (Quarterly)1.65x
EPS Basic Excl Extra (TTM)$-4.09
Inventory Turnover (TTM)1.81x
Pretax Margin (TTM)-93.85%
Price vs S&P 500 (13W)-65.39%
Beta0.08x
P/FCF (Annual)16.06x
Revenue / Share (TTM)$2.41
ROE (TTM)-109.37%
52-Week Low$1.11
Analyst Recommendations
Jun 2025
Jul 2025
Aug 2025
Oct 2025
4.14
4.14
4.14
4.14
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
SDEVStablecoin Development Corporation | 15.34x | -74.73% | 54.56% | — | $1.65 |
| LLYEli Lilly & Co. | 12.36x | 47.44% | 82.83% | 27.59% | $966.99 |
| JNJJohnson & Johnson | 5.53x | 7.87% | 67.95% | 14.90% | $221.43 |
| ABBVABBVIE INC. | 5.83x | 8.57% | 71.62% | -2.88% | $202.78 |
| MRKMerck & Co., Inc. | 4.18x | 2.89% | 78.07% | 21.23% | $111.28 |
| NVONovo-Nordisk A/S | 4.25x | 6.43% | 80.98% | 20.66% | $46.40 |
| NVSNovartis AG | 4.74x | 5.77% | 75.41% | 15.26% | $145.23 |
| AZNAstraZeneca PLC | 4.66x | 9.93% | 81.42% | 21.88% | $181.86 |
| PFEPfizer Inc. | 2.31x | 1.36% | 74.80% | -3.51% | $25.81 |
| ABTAbbott Laboratories | 3.20x | 6.59% | 56.50% | 8.20% | $82.56 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | 2.48x | 4.41% | 52.77% | — | $35.84 |
About
Stablecoin Development Corp is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.